KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis Breadcrumbs UL Home Research Year of Publication 2013 Journal Surgical Oncology-Oxford DOI DOI 10.1016/j.suronc.2013.02.001